Back to 
Capital Research Global InvestorsHAHAE
Capital Research Global InvestorsHAHAEShowing 5 of 28 quarters
Position history for Capital Research Global Investors's holdings in HAEMONETICS CORP MASS
No. Capital Research Global Investors exited its HAE (Haemonetics Corp Mass) position in Q3 2025. Its Q2 2025 13F listed 1,139,043 shares worth $85M. Capital Research Global Investors already held HAE in its Q4 2018 13F, the earliest on record, and held it in 27 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$357.1M
Total Shares Change
-4.4M
Quarter-by-Quarter History
Other major holders of HAE: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.